DE602004027811D1 - Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon - Google Patents

Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon

Info

Publication number
DE602004027811D1
DE602004027811D1 DE602004027811T DE602004027811T DE602004027811D1 DE 602004027811 D1 DE602004027811 D1 DE 602004027811D1 DE 602004027811 T DE602004027811 T DE 602004027811T DE 602004027811 T DE602004027811 T DE 602004027811T DE 602004027811 D1 DE602004027811 D1 DE 602004027811D1
Authority
DE
Germany
Prior art keywords
oxazolidinonantibiotics
derivatives
group substituted
cyclopropyl group
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004027811T
Other languages
English (en)
Inventor
Yasumichi Fukuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Merck Sharp and Dohme LLC
Original Assignee
Kyorin Pharmaceutical Co Ltd
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd, Merck Sharp and Dohme LLC filed Critical Kyorin Pharmaceutical Co Ltd
Publication of DE602004027811D1 publication Critical patent/DE602004027811D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
DE602004027811T 2003-07-02 2004-06-29 Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon Active DE602004027811D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48390403P 2003-07-02 2003-07-02
US54698404P 2004-02-24 2004-02-24
PCT/US2004/020734 WO2005005398A2 (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof

Publications (1)

Publication Number Publication Date
DE602004027811D1 true DE602004027811D1 (de) 2010-08-05

Family

ID=34068173

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027811T Active DE602004027811D1 (de) 2003-07-02 2004-06-29 Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon

Country Status (23)

Country Link
US (2) US7462633B2 (de)
EP (1) EP1646629B1 (de)
JP (1) JP4607107B2 (de)
KR (1) KR20060113625A (de)
AR (1) AR044990A1 (de)
AT (1) ATE471937T1 (de)
AU (1) AU2004256083B2 (de)
BR (1) BRPI0411688A (de)
CA (1) CA2530140C (de)
CL (1) CL2004001678A1 (de)
DE (1) DE602004027811D1 (de)
EC (1) ECSP056257A (de)
IL (1) IL172785A0 (de)
IS (1) IS8178A (de)
MA (1) MA27938A1 (de)
MX (1) MXPA06000228A (de)
MY (1) MY140137A (de)
NO (1) NO20060558L (de)
NZ (1) NZ544237A (de)
PE (1) PE20050732A1 (de)
RU (1) RU2348628C2 (de)
TW (1) TW200510421A (de)
WO (1) WO2005005398A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360238B2 (en) * 2001-04-17 2007-11-15 Kyorin Pharmaceutical Co., Ltd. Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
WO2005019211A2 (en) * 2003-06-03 2005-03-03 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic compounds and methods of making and using the same
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1646629B1 (de) 2003-07-02 2010-06-23 Merck Sharp & Dohme Corp. Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
US20070293493A1 (en) * 2003-07-02 2007-12-20 Milton Hammond Oxazolidinone antibiotics and derivatives thereof
US7129259B2 (en) * 2003-12-17 2006-10-31 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP1799677A1 (de) * 2004-10-08 2007-06-27 Ranbaxy Laboratories Limited Oxazolidinon-derivate mit antimikrobieller funktion
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス,インコーポレイテッド トリアゾール類の合成方法
US20090018123A1 (en) * 2005-06-20 2009-01-15 Milind D Sindkhedkar Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
AR054608A1 (es) * 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
AU2008260647A1 (en) * 2007-05-23 2008-12-11 Merck Sharp & Dohme Corp. Cyclopropyl pyrrolidine orexin receptor antagonists
US8604209B2 (en) 2008-10-10 2013-12-10 Trius Therapeutics, Inc. Methods for preparing oxazolidinones and compositions containing them
KR101739923B1 (ko) 2009-02-03 2017-05-25 머크 샤프 앤드 돔 코포레이션 R)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR20120106697A (ko) 2009-06-26 2012-09-26 파나세아 바이오테크 리미티드 신규 아자비시클로헥산
BR112013007566A2 (pt) 2010-09-28 2016-08-02 Panacea Biotec Ltd novos compostos bicíclicos
WO2017066964A1 (en) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053593A (en) * 1975-11-26 1977-10-11 Lew Frumoff Medical product combining antimicrobial, antiporasitic and vitamin complex
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
AU670842B2 (en) * 1992-12-08 1996-08-01 Pharmacia & Upjohn Company Tropone-substituted phenyloxazolidinone antibacterial agents
TW286317B (de) 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
ATE204874T1 (de) 1995-05-11 2001-09-15 Upjohn Co Spirocyclische und bicyclische diazinyl- und carbazinyloxazolidinone
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
WO2000070758A1 (fr) 1999-05-14 2000-11-23 Kabushiki Kaisha Toshiba Dispositif d'onde acoustique de surface
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
JP2003522763A (ja) 2000-02-10 2003-07-29 ファルマシア・アンド・アップジョン・カンパニー ピペラジンアミド置換基を持つオキサゾリジノンチオアミド
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
NZ522990A (en) * 2000-06-05 2003-08-29 Dong A Pharm Novel oxazolidinone derivatives and a process for the preparation thereof
BR0112826A (pt) * 2000-07-17 2003-06-24 Ranbaxy Lab Ltd Derivados da oxazolidinona como antimicrobianos
AU2001293163A1 (en) * 2000-09-27 2002-04-08 Lynx Therapeutics, Inc. Method for determining relative abundance of nucleic acid sequences
US6689769B2 (en) 2000-12-21 2004-02-10 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
YU52403A (sh) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
AU2002360238B2 (en) * 2001-04-17 2007-11-15 Kyorin Pharmaceutical Co., Ltd. Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
EP1448536A1 (de) 2001-11-29 2004-08-25 Merck & Co., Inc. Cyclopropyl enthaltende oxazolidinonantibiotika und deren derivate
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5-取代噁唑烷酮衍生物及其制备方法和应用
TW200302095A (en) 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7473699B2 (en) 2002-02-28 2009-01-06 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents
BR0310074A (pt) 2002-05-15 2005-03-08 Ranbaxy Lab Ltd Formas polimórficas de derivados de fenil oxazolidinona
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
BR0316690A (pt) 2002-11-28 2005-10-18 Astrazeneca Ab Composto, prodroga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
WO2004089943A1 (en) 2003-04-09 2004-10-21 Pharmacia & Upjohn Company Llc Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
EP1625124A1 (de) 2003-05-06 2006-02-15 Ranbaxy Laboratories, Ltd. Oxazolidinonderivate als antimikrobiellen wirkstoff
EP1656357A1 (de) * 2003-07-02 2006-05-17 Merck & Co., Inc. Oxazolidinonantibiotika und derivate davon
US20070293493A1 (en) * 2003-07-02 2007-12-20 Milton Hammond Oxazolidinone antibiotics and derivatives thereof
EP1646629B1 (de) * 2003-07-02 2010-06-23 Merck Sharp & Dohme Corp. Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
JP2007521283A (ja) * 2003-07-02 2007-08-02 メルク アンド カンパニー インコーポレーテッド シクロプロピル基で置換されたオキサゾリジノン系抗生物質およびその誘導体

Also Published As

Publication number Publication date
AU2004256083A1 (en) 2005-01-20
JP2007521281A (ja) 2007-08-02
MXPA06000228A (es) 2006-06-27
IL172785A0 (en) 2006-06-11
EP1646629B1 (de) 2010-06-23
IS8178A (is) 2005-12-13
JP4607107B2 (ja) 2011-01-05
US7462633B2 (en) 2008-12-09
TW200510421A (en) 2005-03-16
US20070203187A1 (en) 2007-08-30
NO20060558L (no) 2006-02-02
CA2530140A1 (en) 2005-01-20
AR044990A1 (es) 2005-10-12
WO2005005398A3 (en) 2005-04-28
ATE471937T1 (de) 2010-07-15
CA2530140C (en) 2010-11-09
NZ544237A (en) 2008-09-26
AU2004256083B2 (en) 2007-10-11
PE20050732A1 (es) 2005-11-02
US7582659B2 (en) 2009-09-01
WO2005005398A2 (en) 2005-01-20
MY140137A (en) 2009-11-30
US20050038092A1 (en) 2005-02-17
CL2004001678A1 (es) 2005-05-20
RU2348628C2 (ru) 2009-03-10
ECSP056257A (es) 2006-04-19
BRPI0411688A (pt) 2006-12-26
EP1646629A2 (de) 2006-04-19
MA27938A1 (fr) 2006-06-01
RU2005140379A (ru) 2007-08-10
KR20060113625A (ko) 2006-11-02

Similar Documents

Publication Publication Date Title
DE602005009811D1 (de) Tetrahydrocarbazole und derivate
DE602004032276D1 (de) Tetrahydro-Naphthalen und Harnstoffderivate
DE602004027811D1 (de) Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
ATE390426T1 (de) Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
ATE422495T1 (de) Antibakterielle naphthydrin- und quinolinderivate
ATE512965T1 (de) Pyrrolopyrimidin derivate
ATE481402T1 (de) Pyrazolopyridin-derivate
ATE486091T1 (de) Vegf-fallen und therapeutische verwendungen dafür
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
IS8439A (is) Nýjar kínólín afleiður
DE502004001401D1 (de) Zyklonabscheider
MA29039B1 (fr) Dibenzylamines et derives
NO20054136D0 (no) Imidazol-4-yl-etynyl-pyridin-derivater
DE602004004553D1 (de) Chinazolinderivate
DE602004022180D1 (de) Chinazolinderivate
IS8364A (is) N-þíasól-2-ýl-bensamíð afleiður
ATE376549T1 (de) Pyrrolopyridazin derivate
FI20031190A0 (fi) Antioksidantti ja sen käyttö
DK1675852T3 (da) Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
ATE449064T1 (de) Amidoacetonitrilderivate
IS8235A (is) 2-amínóbensóýl afleiður
DE502004003715D1 (de) Selbstsperrender gurtaufroller
DE502004010917D1 (de) Rstellung und verwendung
NO20053898D0 (no) Use and proceeding at footballshoes